Defect in myasthenia gravis is at the level of?
## **Core Concept**
Myasthenia gravis (MG) is a chronic autoimmune disorder characterized by weakness and rapid fatigue of the muscles under voluntary control. It is caused by a defect in the transmission of nerve impulses to muscles. The underlying issue in MG involves the immune system producing antibodies that block or destroy nicotinic acetylcholine receptors (AChR) at the neuromuscular junction.
## **Why the Correct Answer is Right**
The correct answer, , indicates that the defect in myasthenia gravis is at the level of the **post-synaptic membrane**, specifically involving the **acetylcholine receptor (AChR)**. In MG, autoantibodies target the AChR, reducing the number of available receptors for acetylcholine to bind. This decreases the effectiveness of neurotransmission from nerve to muscle, leading to muscle weakness and fatigue. The neuromuscular junction consists of a pre-synaptic neuron terminal, a synaptic cleft, and a post-synaptic muscle membrane. The defect in MG is post-synaptic, affecting the muscle side of the junction.
## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because the defect in MG is not at the **pre-synaptic neuron**. Pre-synaptic disorders would involve issues with neurotransmitter release rather than receptor availability.
- **Option B:** This option is incorrect because the issue is not with the **synaptic cleft** itself but with the receptors on the post-synaptic side.
- **Option D:** This option is incorrect because, while **acetylcholine release** is crucial for neuromuscular transmission, the defect in MG is not with the release mechanism but with the receptors on the muscle side.
## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that myasthenia gravis symptoms often worsen with **repetitive use** of muscles and improve with **rest**. This fluctuation in muscle strength is a hallmark of the disease. Additionally, patients with MG may experience **ocular symptoms** (e.g., double vision, ptosis), **bulbar symptoms** (e.g., difficulty swallowing), and **respiratory symptoms**, which can be life-threatening.
## **Correct Answer:** . Acetylcholine receptor.